Exact Mass: 446.2906
Exact Mass Matches: 446.2906
Found 500 metabolites which its exact mass value is equals to given mass value 446.2906
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-Hydroxy-2,2-bis[2-oxo-2-[[4-[(3-aminopropyl)amino]butyl]amino]ethyl]acetic acid
12-Ketoporrigenin
(3beta,5alpha,6beta,25S)-3,6-Dihydroxyspirostan-12-one is found in onion-family vegetables. (3beta,5alpha,6beta,25S)-3,6-Dihydroxyspirostan-12-one is a constituent of Allium porrum (leek) Constituent of Allium porrum (leek). 12-Ketoporrigenin is found in onion-family vegetables.
Taccagenin
Taccagenin is found in root vegetables. Taccagenin is a constituent of Tacca leontopetaloides (Polynesian arrowroot).
Leontogenin
Leontogenin is found in root vegetables. Leontogenin is a constituent of Tacca leontopetaloides (Polynesian arrowroot). Constituent of Tacca leontopetaloides (Polynesian arrowroot). Leontogenin is found in root vegetables.
24-Oxo-1alpha,23,25-trihydroxyvitamin D3
This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.
3-Hydroxysintaxanthin
Isolated from the peel of Sinton citrangequat. 3-Hydroxysintaxanthin is found in sweet orange, citrus, and avocado. 3-Hydroxysintaxanthin is found in avocado. 3-Hydroxysintaxanthin is isolated from the peel of Sinton citrangequa
Neoporrigenin B
Porrigenin B is found in onion-family vegetables. Porrigenin B is a constituent of Allium porrum (leeks) Constituent of Allium porrum (leeks). Neoporrigenin B is found in onion-family vegetables.
Spirotaccagenin
Spirotaccagenin is found in root vegetables. Spirotaccagenin is a constituent of Tacca leontopetaloides (Polynesian arrowroot) Constituent of Tacca leontopetaloides (Polynesian arrowroot). Spirotaccagenin is found in root vegetables.
Menahydroquinone-4
carpipramine
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
3,7,18-O-triacetylfoliol|3,7,18-triacetylfoliol|3alpha,7beta,18-triacetoxy-ent-kaur-16-ene|foliol triacetate|Triacetylfoliol
methyl-3beta,9beta-dihydroxy-15alpha-senecioyloxy-ent-kaurenoate
(25S)-spirost-5-en-1beta,3beta,14alpha-triol|namogenin B
methyl-3beta,9beta-dihydroxy-15alpha-angeloyloxy-ent-kaurenoate
2alpha-Angeloyloxy-3beta-(2-methylpent-2-enoylxy)isodrimeninol
methyl ent-7alpha,9alpha-dihydroxy-15beta-[(2Z)-2-methyl-but-2-enoyloxy]kaur-16-en-19-oate|Methyl ent-7??,9??-dihydroxy-15??-[(2Z)-2-methyl-but-2-enoyloxy]kaur-16-en-19-oate
methyl-9beta,11beta-dihydroxy-15alpha-angeloyloxy-ent-kaurenoate
8alpha-hydroxy,23alpha-O-ethyl-23,6alpha-epoxy-labd-13(14),17-dien-16(R),19-olide
(3beta,20S,22R,24S)-16,24:20,24-diepoxycholest-5-ene-3,22,25-triol|3,22,25-trihydroxy-16-24,20-24-bisepoxy-(3beta,16alpha,20S,22R,24S)-cholest-5-ene
3alpha-acetoxy-15-hydroxy-18-tigloyloxy-ent-labda-8(17),13E-diene
espinasanolide-(2-methylbutyrate) methyl ester|espinasanolide-<2-methylbutyrate> methyl ester
3alpha,9alpha-di-pent-2E-enoyloxy-8alpha-hydroxy-7beta,10alphaH-eremophil-11-ene
3alpha,9beta,13alpha-trihydroxy-11(12),15(17)-trinervitadiene-3,9,13-triacetate
(2alpha,3bata,5alpha,25R)-Spirost-8(14)-ene-2,3,5-triol
(4R,5S,E)-13-((R)-6-hydroxy-2,8-dimethylchroman-2-yl)-2,6,10-trimethyltrideca-2,6-diene-4,5,10-triol
berkeleyone A
A meroterpenoid found in Penicillium rubrum and has been shown to exhibit inhibitory activity against caspase-1.
1-O-stearoyl-beta-D-glucopyranose|1-O-stearoyl-beta-D-glucopyranoside|1beta-O-Stearoyl-D-glucopyranose|n-octadecanoyl beta-D-glucopyranoside
3beta,9alpha,14alpha-trihydroxycholest-7-en-6,23-dione|grandol G
(23S,25R,26R)-spirost-5-en-3beta,23,26-triol|indiosides M
ent-19-(3-Hydroxy-3-methylglutaroyloxy)beyer-15-en-methyl ester
(1aR,4R,7S,7aR,7bR)-1a,2,4,5,6,7,7a,7b-octahydro-1a-[1-(hydroxymethyl)ethenyl]-7,7a-dimethyl-2-oxonaphth[1,2-b]oxiren-4-yl (4E)-3-hydroxy-2,4,6-trimethyloct-4-enoate|1-(xylarenone A)xylariate A
(2alpha,3bata,5alpha,25R)-Spirost-7-ene-2,3,5-triol
1(15),8(19)-trinervitadiene-2beta,3alpha,14alpha triacetate|Tri-Ac-(2beta,3alpha,14alpha)-1(15),8(19)-Trinervitadiene-2,3,14-triol
2beta,3alpha,9alpha-triacetoxy-1(15),8(19)-trinervitadiene
(1S,4S,5aS,5bR,7aS,11aS,11bR,13R,13aS,13bR)-1,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a,13b-octadecahydro-5b,8,8,11a,13a-pentamethylchryseno[1,2-c]furan-1,4,13-triol 1-acetate|hyrtiosin D
(25S)-spirost-5-ene-3beta,17alpha,27-triol|25(S)-spirost-5-en-3beta,7alpha,27-triol
(2E,4E,6E)-cyclo-[(NMe-L-Ala)-(NMe-L-Val)-(Nalpha-octa-2,4,6-trienoyl-L-Lys)]|sclerotiotide C
7alpha-acetyl-isopimara-8(14),15-dien-18-yl and metyl malonate
11beta-acetoxy-8alpha-hydroxy-12alpha-senecioyloxy-ent-pimar-15-ene
1(15),8(19)-trinervitadiene-2beta,3alpha,13alpha triacetate
C26H38O6_Androsta-11,15-diene-14-carboxylic acid, 3,15,19-trihydroxy-4,4,8,12,16-pentamethyl-17-oxo-, methyl ester
Lovastatin putative derivative C26H38O6 observed in fungal symbiont H
Tetraethylene glycol di(2-ethylhexanoate)
CONFIDENCE standard compound; INTERNAL_ID 1350; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10650; ORIGINAL_PRECURSOR_SCAN_NO 10646 CONFIDENCE standard compound; INTERNAL_ID 1350; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10656; ORIGINAL_PRECURSOR_SCAN_NO 10653 CONFIDENCE standard compound; INTERNAL_ID 1350; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10668; ORIGINAL_PRECURSOR_SCAN_NO 10664 CONFIDENCE standard compound; INTERNAL_ID 1350; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10695; ORIGINAL_PRECURSOR_SCAN_NO 10693 CONFIDENCE standard compound; INTERNAL_ID 1350; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10687; ORIGINAL_PRECURSOR_SCAN_NO 10684 CONFIDENCE standard compound; INTERNAL_ID 1350; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10700; ORIGINAL_PRECURSOR_SCAN_NO 10696
Ala Ile Ile Met
Ala Ile Leu Met
Ala Ile Met Ile
Ala Ile Met Leu
Ala Lys Lys Thr
Ala Lys Thr Lys
Ala Leu Ile Met
Ala Leu Leu Met
Ala Leu Met Ile
Ala Leu Met Leu
Ala Met Ile Ile
Ala Met Ile Leu
Ala Met Leu Ile
Ala Met Leu Leu
Ala Thr Lys Lys
Cys Ile Ile Val
Cys Ile Leu Val
Cys Ile Val Ile
Cys Ile Val Leu
Cys Leu Ile Val
Cys Leu Leu Val
Cys Leu Val Ile
Cys Leu Val Leu
Cys Val Ile Ile
Cys Val Ile Leu
Cys Val Leu Ile
Cys Val Leu Leu
Gly Lys Arg Ser
Gly Lys Ser Arg
Gly Arg Lys Ser
Gly Arg Ser Lys
Gly Ser Lys Arg
Gly Ser Arg Lys
Ile Ala Ile Met
Ile Ala Leu Met
Ile Ala Met Ile
Ile Ala Met Leu
Ile Cys Ile Val
Ile Cys Leu Val
Ile Cys Val Ile
Ile Cys Val Leu
Ile Ile Ala Met
Ile Ile Cys Val
Ile Ile Met Ala
Ile Ile Thr Thr
Ile Ile Val Cys
Ile Leu Ala Met
Ile Leu Cys Val
Ile Leu Met Ala
Ile Leu Thr Thr
Ile Leu Val Cys
Ile Met Ala Ile
Ile Met Ala Leu
Ile Met Ile Ala
Ile Met Leu Ala
Ile Thr Ile Thr
Ile Thr Leu Thr
Ile Thr Thr Ile
Ile Thr Thr Leu
Ile Val Cys Ile
Ile Val Cys Leu
Lys Ala Lys Thr
Lys Ala Thr Lys
Lys Gly Arg Ser
Lys Gly Ser Arg
Lys Lys Ala Thr
Lys Lys Thr Ala
Lys Arg Gly Ser
Lys Arg Ser Gly
Lys Ser Gly Arg
Lys Ser Arg Gly
Lys Thr Ala Lys
Lys Thr Lys Ala
Leu Ile Thr Thr
Leu Leu Thr Thr
Leu Thr Ile Thr
Leu Thr Leu Thr
Leu Thr Thr Ile
Leu Thr Thr Leu
Arg Gly Lys Ser
Arg Gly Ser Lys
Arg Lys Gly Ser
Arg Lys Ser Gly
Arg Ser Gly Lys
Arg Ser Lys Gly
Ser Gly Lys Arg
Ser Gly Arg Lys
Ser Lys Gly Arg
Ser Lys Arg Gly
Ser Arg Gly Lys
Ser Arg Lys Gly
Thr Ala Lys Lys
Thr Ile Ile Thr
Thr Ile Leu Thr
Thr Ile Thr Ile
Thr Ile Thr Leu
Thr Lys Ala Lys
Thr Lys Lys Ala
Thr Leu Ile Thr
Thr Leu Leu Thr
Thr Leu Thr Ile
Thr Leu Thr Leu
Thr Thr Ile Ile
Thr Thr Ile Leu
Thr Thr Leu Ile
Thr Thr Leu Leu
(24R)-24-fluoro-1α,25-dihydroxyvitamin D2 / (24R)-24-fluoro-1α,25-dihydroxyergocalciferol
(24S)-24-fluoro-1α,25-dihydroxyvitamin D2 / (24S)-24-fluoro-1α,25-dihydroxyergocalciferol
(23S,25R)-1α,25-dihydroxyvitamin D3 26,23-lactol / (23S,25R)-1α,25-dihydroxycholecalciferol 26,23-lactol
(5Z,7E)-(1S,3R,23R)-1,3,23,25-tetrahydroxy-9-10-seco-5,7,10(19)-cholestatrien-24-one
(5Z,7E)-(1S,3R,23S)-1,3,23,25-tetrahydroxy-9-10-seco-5,7,10(19)-cholestatrien-24-one
7alpha,12alpha-dihydroxy-3-oxocholest-4-en-26-oic acid
12-Ketoporrigenin
Neoporrigenin B
Leontogenin
Taccagenin
Spirotaccagenin
3-Hydroxysintaxanthin
(R)-4-((3S,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-7,11-dioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
bhas#32
An (omega-1)-hydroxy fatty acid ascaroside that is ascr#32 in which the pro-R hydrogen that is beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
bhos#32
An omega-hydroxy fatty acid ascaroside that is oscr#32 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
(24R)-24-fluoro-1alpha,25-dihydroxyvitamin D2
(24S)-24-fluoro-1alpha,25-dihydroxyvitamin D2
(23S,25R)-1alpha,25-dihydroxyvitamin D3 26,23-lactol / (23S,25R)-1alpha,25-dihydroxycholecalciferol 26,23-lactol
(23R)-1alpha,23,25-trihydroxy-24-oxovitamin D3
(23S)-1alpha,23,25-trihydroxy-24-oxovitamin D3
N-Carbobenzoxy-D-leucine DicyclohexylaMMoniuM Salt
9,9-DiMethylfluorene-2,7-diboronic acid bis(pinacol) ester
(2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-amino-1,6-diphenylhexane
3-ALPHA-HYDROXY-6-OXO-5-ALPHA-CHOLAN-24-OIC ACID METHYL ESTER 3-ACETATE
D-Valine, 3-Methyl-N-[(phenylmethoxy)carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)
Hydrocortisone Valerate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
[11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(3R,17R)-17-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxyoctadecanoic acid
23-acetoxy-12-O-deacetyl-12-epi-deoxoscalarin
A scalarane sesterterpenoid that is 23-acetoxy-12-epi-deoxoscalarin in which the acetoxy group at position 12 is replaced by a hydroxy group. It has been isolated from the sponge, Hyattella species.
(4R)-4-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-7,11-dioxo-2,3,5,6,8,9,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
(5s,8r,9s,10s,13r,14s,17s)-13-{2-[(3,5-Difluorobenzyl)oxy]ethyl}-17-Hydroxy-10-Methylhexadecahydro-3h-Cyclopenta[a]phenanthren-3-One
N-[(2R,3S)-1-((2S)-2-{[(Cyclopentylamino)carbonyl]amino}-3-methylbutanoyl)-2-(1-formyl-1-cyclobutyl)pyrrolidinyl]cyclopropanecarboxamide
(3R)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxystearic acid
(6R)-6-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2,4-dihydroxy-2-methylheptan-3-one
D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-24,24-dihydroxy-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenal
[3-Carboxy-2-(15-carboxy-7-hydroxypentadecanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(15-carboxy-8-hydroxypentadecanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(15-carboxy-4-hydroxypentadecanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(15-carboxy-6-hydroxypentadecanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(15-carboxy-3-hydroxypentadecanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(15-carboxy-5-hydroxypentadecanoyl)oxypropyl]-trimethylazanium
(1S)-1,23,25-trihydroxy-24-oxocalciol
D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
[(17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate
N-[2-[1-[(4-methoxy-3-methylphenyl)methyl]-4-piperidinyl]-3-pyrazolyl]-4-phenylbutanamide
N-(3alpha-hydroxy-7-oxo-5beta-cholan-24-oyl)glycinate
1-(3-cyanophenyl)-3-[[(2R,4S,5R)-5-(5-cyclohexyl-2-methylpyrazol-3-yl)-1-azabicyclo[2.2.2]octan-2-yl]methyl]urea
1-cyclohexyl-3-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-cyclohexyl-3-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-cyclohexyl-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-cyclohexyl-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-cyclohexyl-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-[2-[4-[(8S,9R,10R)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8R,9S,10S)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8S,9S,10S)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[(8R,9S,10R)-9-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(2-pyridinyl)ethanone
1-cyclohexyl-3-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-cyclohexyl-3-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-cyclohexyl-3-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-cyclohexyl-3-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-cyclohexyl-3-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea
1-cyclohexyl-3-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-cyclohexyl-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-cyclohexyl-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-cyclohexyl-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-cyclohexyl-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-[2-[4-[(8R,9R,10R)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8R,9R,10S)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8S,9S,10R)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8R,9S,10R)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
1-[2-[4-[(8S,9R,10S)-10-(hydroxymethyl)-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]ethynyl]-1-cyclopentanol
(6R)-6-[(7R,10R,12S,13R,17R)-7,12-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid
(1-acetyloxy-3-hydroxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
(1-butanoyloxy-3-hydroxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
(1-hexanoyloxy-3-hydroxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-Carboxy-3-(2-heptanoyloxy-3-hexanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(2-decanoyloxy-3-propanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(2-octanoyloxy-3-pentanoyloxypropoxy)propyl]-trimethylazanium
[3-(3-Acetyloxy-2-undecanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium
[3-(3-Butanoyloxy-2-nonanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
(4r,5s,10s)-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,6-diene-4,5,10-triol
(2e)-2-[(3,4-dihydroxyphenyl)methylidene]-3-oxoicosanoic acid
4-[(1e)-2-[(1r,2r,3s,4r,4ar,8as)-2,3-dihydroxy-4-{[(2s)-2-isopropyloxiran-2-yl]methoxy}-1,2,4a,5-tetramethyl-4,7,8,8a-tetrahydro-3h-naphthalen-1-yl]ethenyl]-5h-furan-2-one
(2e,4e,6e)-n-[(3s,6s,9s)-2-hydroxy-6-isopropyl-3,4,7-trimethyl-5,8-dioxo-1,4,7-triazacyclotridec-1-en-9-yl]octa-2,4,6-trienimidic acid
5-hydroxy-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydro-1h-naphthalen-2-yl 5-[(2-methylbut-2-enoyl)oxy]hex-2-enoate
(1r,3as,7s,8r,9ar,9br,11ar)-3a,7,8-trihydroxy-1-[(2r)-6-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(4r)-4-[(1r,3ar,4s,5ar,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-10-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
1a-(3-hydroxyprop-1-en-2-yl)-7,7a-dimethyl-2-oxo-4h,5h,6h,7h,7bh-naphtho[1,2-b]oxiren-4-yl 3-hydroxy-2,4,6-trimethyloct-4-enoate
[(1r,4s,4as,7s,8r,10as)-8-(acetyloxy)-7-ethenyl-4-hydroxy-1,4a,7-trimethyl-3,4,5,6,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 2-methylbutanoate
(1s,3ar,7r,8s,9as,9bs,11as)-3a,7,8-trihydroxy-1-[(2s)-6-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(1s,2r,4s,6r,9r,10s,11s,13r,14s,15r,18s,20s)-13,18-dihydroxy-6-isopropyl-9,11,15-trimethyl-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docosane-7,21-dione
[(1r,4s,4as,7s,8r,10as)-8-(acetyloxy)-7-ethenyl-4-hydroxy-1,4a,7-trimethyl-3,4,5,6,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl (2r)-2-methylbutanoate
(1r,2r,4as,5r,8ar)-5-hydroxy-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydro-1h-naphthalen-2-yl (2z,5r)-5-{[(2z)-2-methylbut-2-enoyl]oxy}hex-2-enoate
(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,16's)-5-(hydroxymethyl)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-5,16'-diol
15',16'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one
(4s,5s,10s)-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,6-diene-4,5,10-triol
(1r,5as,5br,7ar,8r,11ar,11br,13s,13as,13bs)-1-hydroxy-8-(hydroxymethyl)-5b,8,11a,13a-tetramethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-13-yl acetate
(3s,4s,5s)-3-[15-(2h-1,3-benzodioxol-5-yl)pentadecyl]-4-hydroxy-5-methyloxolan-2-one
5,5-bis(hydroxymethyl)-7',9',13'-trimethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-ol
(1r,4s,11r)-11-hydroxy-7-(hydroxymethyl)-4-(4-methoxy-4-methylpent-2-en-1-yl)-4,11-dimethyl-8-oxocycloundeca-2,6,9-trien-1-yl 3-methylbut-2-enoate
(1'r,2r,2's,4's,5r,7's,8's,9's,12's,13'r,16's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-4',8',16'-triol
(1r,6s,7r,10r,11r,12s,15s)-7,10-bis(acetyloxy)-6,12,16-trimethyl-2-methylidenetricyclo[7.5.2.0¹²,¹⁵]hexadec-9(16)-en-11-yl acetate
methyl (1s,4s,5s,6s,9r,10r,13r,15s)-6,10-dihydroxy-5,9-dimethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
(4r,5s,6e,10s)-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,6-diene-4,5,10-triol
18-o-methylvibsanin g
{"Ingredient_id": "HBIN002147","Ingredient_name": "18-o-methylvibsanin g","Alias": "NA","Ingredient_formula": "C26H38O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14799","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}